SedaSerraToluMD

PubMed

• Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-...
  Brian Estrella, Mark M Francescone, Yun Kyoung Ryu Tiger, Salvia Jain, Stefan K Barta, Seda Tolu, Ahmed Sawas, Jennifer K Lue, Barbara Pro, Jennifer E Amengual> ;Leukemia & Lymphoma. 2024 Mar 22
• Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer.
  Riya Patel, Abdissa Negassa, Seda S Tolu, Ana Acuna-Villaorduna, Sanjay Goel> ;Clinical Colorectal Cancer. 2024 Mar 1
• Queen's gambit: response-adapted win in CAYA with cHL.
  Seda S Tolu, Jennifer E Amengual> ;Blood. 2023 Apr 27
• Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
  Seda S Tolu, Layla Van Doren> ;Transfusion and Apheresis Science. 2022 Oct 1
• 7 citations
  Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and Other Small Molecule Kinase Inhibitors-United States, July 2016-June 2019.
  Jeremy A W Gold, Seda S Tolu, Tom Chiller, Kaitlin Benedict, Brendan R Jackson> ;Clinical Infectious Diseases. 2022 Aug 25
• Progression of untreated gastric and pulmonary metastasis in a patient with resected acral melanoma.
  Gurasees S Chawla, Seda S Tolu, Shitij Arora> ;BMJ Case Reports. 2022 Mar 9
• 6 citations
  Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
  Seda S Tolu, Andrew Crouch, Jaeun Choi, Qi Gao, Moramaya Reyes-Gil, Ugochi Olivia Ogu, Giacomo Vinces, Caterina P Minniti> ;Annals of Hematology. 2022 Mar 1
• A Search for Secondary Hypertension: “Where’s Waldo?”
  Seda Serra Tolu, Neelja Kumar, Shitij Arora> ;Cureus. 2021 Jun 16
• First Report of Compound Heterozygosity for Hb S ( HBB : c.20A>T) and Hb Haringey ( HBB : c.131A>G).
  Ugochi O. Ogu, Morayma Reyes Gil, Seda S. Tolu, Seetharama A. Acharya, Caterina P. Minniti> ;Hemoglobin. 2021 Jun 16
• 13 citations
  Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells.
  Seda S. Tolu, Kai Wang, Zi Yan, Shouping Zhang, Karl Roberts, Andrew Crouch, Gracy Sebastian, Mark Chaitowitz, Eric D. Fornari, Evan M. Schwechter, Joan Uehlinger, Dee...> ;Cells. 2020 Sep 24
• HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines
  Caterina P. Minniti, Seda S. Tolu, Kai Wang, Zi Yan, Karl Robert, Shouping Zhang, Andrew Crouch, Joan Uehlinger, Deepa Manwani, Eric E. Bouhassira> ;Cells. 2020 Sep 29
• 3 citations
  Hemoglobin F mitigation of sickle cell complications decreases with aging.
  Seda S. Tolu, Morayma Reyes‐Gil, Ugochi O. Ogu, Merin Thomas, Eric E. Bouhassira, Caterina P. Minniti> ;American Journal of Hematology. 2020 May 1
• 96 citations
  Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
  Margarita Kushnir, Yun Choi, Ruth Eisenberg, Devika Rao, Seda S. Tolu, Jackson Gao, Wenzhu B. Mowrey, Henny H. Billett> ;The Lancet. Haematology. 2019 Jul 1
• 10 citations
  Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.
  Kai Wang, Anthony K. Guzman, Zi Yan, Shouping Zhang, Michael Y. Hu, Mehdi B. Hamaneh, Yi-Kuo Yu, Seda S. Tolu, Jinghang Zhang, Holly E. Kanavy, Kenny Ye, Boris Barthol...> ;Cell Reports. 2019 Mar 5
• 2 citations
  Agranulocytosis from Outpatient Antimicrobial Treatment with Ceftriaxone: A Case Report.
  Yevgeniy Genchanok, Seda S. Tolu, Heidy Wang, Shitij Arora> ;The Permanente Journal. 2019 Jan 1
• 65 citations
  Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.
  Ashkan Emadi, Rawan Faramand, Brandon Carter-Cooper, Seda Tolu, Laurie A. Ford, Rena G. Lapidus, Meir Wetzler, Eunice S. Wang, Arash Etemadi, Elizabeth A. Griffiths> ;American Journal of Hematology. 2015 May 1
• Join now to see all

Lectures

• The impact of biologic agents in patients with metastatic colorectal cancer by race/ethnicity. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
• Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• High Hemoglobin F in Sickle Cell Disease: Waning Protection with Age 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019